Pathway-Based Evaluation in Early Onset Colorectal Cancer Suggests Focal Adhesion and Immunosuppression along with Epithelial-Mesenchymal Transition
暂无分享,去创建一个
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] T. Jenssen,et al. A literature network of human genes for high-throughput analysis of gene expression , 2001, Nature Genetics.
[3] K. Hatakeyama,et al. Expression of Fas ligand is an early event in colorectal carcinogenesis , 2001, Journal of surgical oncology.
[4] M. Kaneko,et al. CD15 expression in mature granulocytes is determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV. , 2001, The Journal of biological chemistry.
[5] Hisashi Narimatsu,et al. CD15 Expression in Mature Granulocytes Is Determined by α1,3-Fucosyltransferase IX, but in Promyelocytes and Monocytes by α1,3-Fucosyltransferase IV* , 2001, The Journal of Biological Chemistry.
[6] J. Bach. Regulatory T cells under scrutiny , 2003, Nature Reviews Immunology.
[7] J. Bach. Regulatory lymphocytes: Regulatory T cells under scrutiny , 2003, Nature Reviews Immunology.
[8] A. Mercurio,et al. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. , 2003, Molecular biology of the cell.
[9] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[10] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[11] S. Fu,et al. TGF‐β Induces Foxp3 + T‐Regulatory Cells from CD4 + CD25 − Precursors , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] William R Sellers,et al. The biology and clinical relevance of the PTEN tumor suppressor pathway. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] N. Zhang,et al. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] Seong-Jin Kim,et al. Transforming growth factor-beta : biology and clinical relevance. , 2005, Journal of biochemistry and molecular biology.
[15] Seong-Jin Kim,et al. Transforming Growth Factor-β: Biology and Clinical Relevance , 2005 .
[16] Gábor Csárdi,et al. The igraph software package for complex network research , 2006 .
[17] A. Chorny,et al. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. , 2006, Arthritis and rheumatism.
[18] H. Andreyev,et al. A “field change” of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma , 2006, Journal of Clinical Pathology.
[19] Robert D. Schreiber,et al. Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.
[20] Hailing Lu,et al. Immunoediting of Cancers May Lead to Epithelial to Mesenchymal Transition1 , 2006, The Journal of Immunology.
[21] T. Wu,et al. Prospects of RNA interference therapy for cancer , 2006, Gene Therapy.
[22] E. González-Rey,et al. A Novel Mechanism for Immunosuppression: from Neuropeptides to Regulatory T Cells , 2006, Journal of Neuroimmune Pharmacology.
[23] Richard A Flavell,et al. Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.
[24] K. Ho,et al. A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.
[25] M. Manjili,et al. Tumor immunoediting and immunosculpting pathways to cancer progression. , 2007, Seminars in cancer biology.
[26] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[27] R. Mirimanoff,et al. CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. , 2008, Cancer research.
[28] M. Schwaiger,et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. , 2008, Cancer cell.
[29] J. Parsons,et al. Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention , 2008, Clinical Cancer Research.
[30] B. Jiang,et al. PI3K/PTEN signaling in tumorigenesis and angiogenesis. , 2008, Biochimica et biophysica acta.
[31] J. Niederkorn. Immune escape mechanisms of intraocular tumors , 2009, Progress in Retinal and Eye Research.
[32] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[33] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[34] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[35] M. Mihm,et al. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. , 2009, Cancer immunity.
[36] Z. Szallasi,et al. Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples , 2009, PloS one.
[37] M. Bertagnolli,et al. Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.
[38] M. Röcken. Early tumor dissemination, but late metastasis: insights into tumor dormancy. , 2010, The Journal of clinical investigation.
[39] A. Prasse,et al. Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. , 2010, American journal of respiratory and critical care medicine.
[40] D. Mcgregor,et al. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis , 2011, Molecular Cancer.
[41] K. Reavis,et al. CCN1 induces a reversible epithelial–mesenchymal transition in gastric epithelial cells , 2010, Laboratory Investigation.
[42] A. Yuryev,et al. Atlas of Signaling for Interpretation of Microarray Experiments , 2010, PloS one.
[43] D. Radisky,et al. Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells. , 2010, Cancer research.
[44] A. Bajo,et al. Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1. , 2010, Cancer letters.
[45] Susumu Goto,et al. KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..
[46] S. Lim,et al. p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase. , 2011, Cancer research.
[47] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[48] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[49] Yuzhuo Wang,et al. The immunoregulatory mechanisms of carcinoma for its survival and development , 2011, Journal of experimental & clinical cancer research : CR.